Biocryst Pharmaceuticals Inc (BCRX)

4.49
1.10 20.00
NASDAQ : Health Care
Prev Close 5.60
Open 5.50
Day Low/High 5.37 / 5.61
52 Wk Low/High 1.63 / 15.96
Volume 1.37M
Avg Volume 992.10K
Exchange NASDAQ
Shares Outstanding 73.76M
Market Cap 413.05M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Notable Thursday Option Activity: BCRX, AXDX, HUM

Notable Thursday Option Activity: BCRX, AXDX, HUM

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in BioCryst Pharmaceuticals, Inc. , where a total of 16,282 contracts have traded so far, representing approximately 1.6 million underlying shares.

Biotech Premarket Movers: Progenics, Alexion, BioCryst

Biotech Premarket Movers: Progenics, Alexion, BioCryst

Progenics, Alexion and BioCryst were among the biotech stock movers in premarket trading on Thursday.

Premarket Biotech Movers: Synergy, Arrowhead, BioCryst

Premarket Biotech Movers: Synergy, Arrowhead, BioCryst

Synergy Pharmaceuticals, Arrowhead Pharmaceuticals and BioCryst Pharmaceuticals were among the biotech stock movers in premarket trading on Wednesday.

Commit To Buy BioCryst Pharmaceuticals At $3, Earn 52.5% Annualized Using Options

Commit To Buy BioCryst Pharmaceuticals At $3, Earn 52.5% Annualized Using Options

Investors considering a purchase of BioCryst Pharmaceuticals, Inc. stock, but tentative about paying the going market price of $5.90/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Big-Cap Tech Names, Biotechs, Oils Lifting Market

Big-Cap Tech Names, Biotechs, Oils Lifting Market

The number of new 12-month highs has climbed to 240.

Finally Getting Back to a Stock Picker's Market

Finally Getting Back to a Stock Picker's Market

The euphoria has calmed down, and if stocks can consolidate, we will have some better entry points.

Shark Bites: What, Market Worry?

Shark Bites: What, Market Worry?

Talk about Dow 20,000 is probably feeding off itself.

Commit To Purchase BioCryst Pharmaceuticals At $4, Earn 68.9% Annualized Using Options

Commit To Purchase BioCryst Pharmaceuticals At $4, Earn 68.9% Annualized Using Options

Investors eyeing a purchase of BioCryst Pharmaceuticals, Inc. shares, but cautious about paying the going market price of $4.61/share, might benefit from considering selling puts among the alternative strategies at their disposal.

5 Stocks Under $10 That Could Make You a Lot of Money

5 Stocks Under $10 That Could Make You a Lot of Money

These stocks trading for less than $10 a share are within range of triggering big breakout trades. Here's how to trade them from here.

8 Stocks Under $10 to Trade for Huge Profits

8 Stocks Under $10 to Trade for Huge Profits

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits

Short Interest Falls 12% For BCRX

Short Interest Falls 12% For BCRX

The most recent short interest data has been released for the 06/15/2016 settlement date, which shows a 750,347 share decrease in total short interest for BioCryst Pharmaceuticals, Inc. , to 5,528,343, a decrease of 11.95% since 05/31/2016.